AngioDynamics, Inc. ANGO
NASDAQ
| 08/31/2026 | 05/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -6.57% | 10.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.57% | 10.44% | |||
| Cost of Revenue | -14.46% | 7.82% | |||
| Gross Profit | 0.14% | 12.76% | |||
| SG&A Expenses | 2.59% | 8.42% | |||
| Depreciation & Amortization | 0.40% | 1.87% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.44% | 8.73% | |||
| Operating Income | -11.88% | 12.12% | |||
| Income Before Tax | 33.88% | -36.71% | |||
| Income Tax Expenses | -153.78% | 2,983.33% | |||
| Earnings from Continuing Operations | 37.77% | -41.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.77% | -41.08% | |||
| EBIT | -11.88% | 12.12% | |||
| EBITDA | -133.14% | 57.88% | |||
| EPS Basic | 38.24% | -40.76% | |||
| Normalized Basic EPS | 3.49% | -317.60% | |||
| EPS Diluted | 37.84% | -40.76% | |||
| Normalized Diluted EPS | 3.49% | -317.60% | |||
| Average Basic Shares Outstanding | 0.78% | 0.24% | |||
| Average Diluted Shares Outstanding | 0.78% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||